Five notes:
- Teladoc reported an $84.3 million net loss compared with the third quarter of 2020, according to an Oct. 27 news release. The loss reflects high expenses associated with Livongo stocks awarded in a merger with the company. It also includes the amortization of acquired debts from acquiring Livongo and InTouch Health.
- Despite losing millions in the third quarter, Teladoc recorded growth of 113 percent year over year, according to the release.
- Paid memberships have grown 2 percent in the United States, whereas visits have grown 40 percent year over year in the third quarter.
- For the fourth quarter of 2021, Teladoc expects total revenue between $536 million and $546 million. The telehealth platform plans to grow its U.S. paid memberships to between 52.5 million and 53.5 million members. Total virtual care visits are expected to reach 3.4 million to 4.1 million.
- For 2021, Teladoc anticipates revenue to surpass $2 billion. Total visits for 2021 are expected to range from 14.5 million to 14.7 million.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
